Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home Retinal Imaging Using NOTAL-OCT V3.0

NCT04241198 is registered in ClinicalTrials.gov with Notal Vision Ltd. as lead sponsor.

NCT NCT04241198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04241198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home Retinal Imaging Using NOTAL-OCT V3.0
Lead sponsor
Notal Vision Ltd.
Phase
Observational
Overall status
Completed
Start date
June 9, 2020
Completion date
March 28, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

a. amd patients, where at least one eye is with active cnv, presenting retinal fluid at the enrolment visit, undergoing active anti-vegf treatment